Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data
Objective Osteoarthritis (OA) affects 10% of adults in the UK. Despite over one-third of people with OA experiencing chronic pain, few studies have examined the population-level impact of chronic pain associated with OA. We compared resource-use and epidemiological outcomes in patients with mild, mo...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/11/e073096.full |
| _version_ | 1797213063150043136 |
|---|---|
| author | Roger Knaggs Christoph Lohan Alastair J Dickson Greg Coates Peter Clewes Hannah Stevenson Lucy Massey |
| author_facet | Roger Knaggs Christoph Lohan Alastair J Dickson Greg Coates Peter Clewes Hannah Stevenson Lucy Massey |
| author_sort | Roger Knaggs |
| collection | DOAJ |
| description | Objective Osteoarthritis (OA) affects 10% of adults in the UK. Despite over one-third of people with OA experiencing chronic pain, few studies have examined the population-level impact of chronic pain associated with OA. We compared resource-use and epidemiological outcomes in patients with mild, moderate and severe chronic OA-associated pain and matched controls without known OA.Design Retrospective, longitudinal, observational cohort study (July 2008 to June 2019).Setting Electronic records extracted from Clinical Practice Research Datalink GOLD primary care linked to Hospital Episode Statistics (HES).Participants Patients (cases; n=23 016) aged ≥18 years with chronic OA-associated pain. Controls (n=23 016) without OA or chronic pain matched on age, sex, comorbidity burden, general practitioner practice and available HES data.Interventions None.Primary and secondary outcome measures Total healthcare resource use (HCRU), direct healthcare costs in 0–12, 12–24 and 24–36 months postindex. Secondary outcomes included incidence and prevalence of chronic OA-associated pain and pharmacological management.Results HCRU was consistently greater in cases versus controls for all resource categories during preindex and postindex periods. Across follow-up periods, resource use was greatest in patients with severe pain. In the first 12 months postindexing, mean total costs incurred by cases were four times higher versus matched controls (£256 vs £62); costs were approximately twice as high in cases vs controls for months 12–24 (£166 vs £86) and 24–36 (£150 vs £81; all p<0.0001). The incidence of new cases of chronic pain associated with OA was 2.64 per 1000 person-years; the prevalence was 1.4%.Conclusions This study highlights the real-world cost of chronic pain associated with OA in cases versus matched controls. We included patients with mild, moderate and severe pain associated with OA, and showed HCRU in discrete 1-year time frames. The true economic burden of pain associated with OA is likely to be considerably higher when indirect costs are considered. |
| first_indexed | 2024-03-09T14:08:58Z |
| format | Article |
| id | doaj.art-9bcf4da15e094625b7eba9f24631992d |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-24T10:52:19Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-9bcf4da15e094625b7eba9f24631992d2024-04-12T10:00:09ZengBMJ Publishing GroupBMJ Open2044-60552023-11-01131110.1136/bmjopen-2023-073096Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care dataRoger Knaggs0Christoph Lohan1Alastair J Dickson2Greg Coates3Peter Clewes4Hannah Stevenson5Lucy Massey6Pain Centre Versus Arthritis and NIHR Nottingham Biomedical Research Centre, School of Pharmacy, University of Nottingham, Nottingham, UKPfizer Australia Pty Ltd, Sydney, New South Wales, AustraliaPrimary Care Rheumatology & Musculoskeletal Medicine Society, York, UKPfizer Ltd, Tadworth, UKPfizer Ltd, Tadworth, UKPfizer Ltd, Tadworth, UKAdelphi Real World, Bollington, UKObjective Osteoarthritis (OA) affects 10% of adults in the UK. Despite over one-third of people with OA experiencing chronic pain, few studies have examined the population-level impact of chronic pain associated with OA. We compared resource-use and epidemiological outcomes in patients with mild, moderate and severe chronic OA-associated pain and matched controls without known OA.Design Retrospective, longitudinal, observational cohort study (July 2008 to June 2019).Setting Electronic records extracted from Clinical Practice Research Datalink GOLD primary care linked to Hospital Episode Statistics (HES).Participants Patients (cases; n=23 016) aged ≥18 years with chronic OA-associated pain. Controls (n=23 016) without OA or chronic pain matched on age, sex, comorbidity burden, general practitioner practice and available HES data.Interventions None.Primary and secondary outcome measures Total healthcare resource use (HCRU), direct healthcare costs in 0–12, 12–24 and 24–36 months postindex. Secondary outcomes included incidence and prevalence of chronic OA-associated pain and pharmacological management.Results HCRU was consistently greater in cases versus controls for all resource categories during preindex and postindex periods. Across follow-up periods, resource use was greatest in patients with severe pain. In the first 12 months postindexing, mean total costs incurred by cases were four times higher versus matched controls (£256 vs £62); costs were approximately twice as high in cases vs controls for months 12–24 (£166 vs £86) and 24–36 (£150 vs £81; all p<0.0001). The incidence of new cases of chronic pain associated with OA was 2.64 per 1000 person-years; the prevalence was 1.4%.Conclusions This study highlights the real-world cost of chronic pain associated with OA in cases versus matched controls. We included patients with mild, moderate and severe pain associated with OA, and showed HCRU in discrete 1-year time frames. The true economic burden of pain associated with OA is likely to be considerably higher when indirect costs are considered.https://bmjopen.bmj.com/content/13/11/e073096.full |
| spellingShingle | Roger Knaggs Christoph Lohan Alastair J Dickson Greg Coates Peter Clewes Hannah Stevenson Lucy Massey Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data BMJ Open |
| title | Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data |
| title_full | Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data |
| title_fullStr | Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data |
| title_full_unstemmed | Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data |
| title_short | Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data |
| title_sort | estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in england a retrospective analysis of linked primary and secondary care data |
| url | https://bmjopen.bmj.com/content/13/11/e073096.full |
| work_keys_str_mv | AT rogerknaggs estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata AT christophlohan estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata AT alastairjdickson estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata AT gregcoates estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata AT peterclewes estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata AT hannahstevenson estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata AT lucymassey estimatingthecostandepidemiologyofmildtoseverechronicpainassociatedwithosteoarthritisinenglandaretrospectiveanalysisoflinkedprimaryandsecondarycaredata |